Edoxaban

Details

Files

Generic Name:

Edoxaban

Project Status:

Complete

Therapeutic Area:

Nonvalvular atrial fibrillation, prevention of stroke and systemic embolism.

Manufacturer:

Daiichi Sankyo, Inc.

Call for patient/clinician input open:

June 8, 2016

Brand Name:

Lixiana NVAF

Project Line:

Reimbursement Review

Project Number:

SR0500-000

Call for patient/clinician input closed:

July 28, 2016

NOC Status at Filing:

Pre NOC

Submission Type:

Initial

Indications:

Nonvalvular atrial fibrillation, prevention of stroke and systemic embolism

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

March 21, 2017

Last Updated : June 8, 2016